Acutus Medical (AFIB) Osake Kurssi
Acutus Medical Kurssi
Liikevaihto on kasvanut 45,0 % vuodessa viimeisten 6 vuoden aikana 20,16 M USD:een. Acutus Medicaln nettomarginaali on nyt −47,4 %, noussut −1 204,9 %:sta muutama vuosi sitten.
Acutus Medical osakekurssi
Acutus Medical liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Acutus Medical -osakkeesta
The business model of Acutus Medical Inc. revolves around medical technologies and solutions for cardiac arrhythmia treatment. Acutus Medical specializes in developing and commercializing innovative electrophysiology platforms and mapping systems that provide real-time, high-resolution mapping of the heart. With a focus on improving the accuracy and efficiency of procedures, Acutus Medical's products enable physicians to better diagnose and treat arrhythmias. The company's advanced technology aims to enhance patient outcomes and streamline healthcare delivery. Acutus Medical Inc. is committed to advancing the field of electrophysiology through continuous innovation and collaboration with healthcare professionals.
Acutus Medical Inc is primarily active in the healthcare industry, specifically focusing on medical devices and technologies for the treatment of cardiac arrhythmias. With their innovative solutions and advanced visualization technologies, Acutus Medical aims to improve the diagnosis and treatment of cardiac arrhythmias, providing physicians with real-time, precise, and detailed information to guide their procedures. By combining electrophysiology and imaging, Acutus Medical revolutionizes how cardiac arrhythmias are managed, offering potential benefits for patients and healthcare professionals in the field of cardiac care.
The main competitors of Acutus Medical Inc in the market include companies such as Biosense Webster, Abbott Laboratories, and Boston Scientific Corporation.
Acutus Medical Inc. is a medical technology company specializing in providing cardiac mapping and ablation systems for the treatment of complex arrhythmias. Founded in 2011, the company has quickly gained recognition for its innovative solutions in electrophysiology. Acutus Medical Inc. is committed to improving patients' lives by providing advanced technologies that enable physicians to diagnose and treat cardiac conditions more accurately and effectively. With a team of experienced professionals and a commitment to research and development, Acutus Medical Inc. continues to be at the forefront of advancing medical technology in the field of electrophysiology. From its inception, the company has focused on revolutionizing the way cardiac arrhythmias are diagnosed and treated, making them a trusted name in the healthcare industry.
Acutus Medical Inc has achieved several significant milestones in its history. One notable accomplishment was the development and introduction of the AcQMap imaging and mapping system, which revolutionized cardiac electrophysiology procedures by providing highly detailed 3D mapping of the heart. The company also made strides in expanding its global presence through strategic partnerships and key regulatory approvals. Moreover, Acutus Medical Inc successfully completed its initial public offering (IPO) in 2019, further strengthening its financial position and enabling continued innovation in the field of electrophysiology. These achievements have solidified Acutus Medical Inc's reputation as a leading player in the cardiac mapping and ablation market.
Acutus Medical Inc is primarily present in various countries and regions around the world. The company has a global presence, with a focus on key markets such as the United States, Europe, and Asia. Acutus Medical Inc has established a strong presence in the United States, where it is headquartered and operates its main operations. Additionally, the company has expanded its footprint in Europe, targeting countries like Germany, France, and the United Kingdom. Acutus Medical Inc is also actively present in the Asia-Pacific region, with a particular focus on markets in Japan, China, and Australia.
Acutus Medical Inc represents a strong commitment to innovation, cutting-edge technology, and delivering optimal patient care. The company's corporate philosophy focuses on developing advanced solutions for cardiac arrhythmia treatment, empowering healthcare professionals, and improving patient outcomes. Acutus Medical is dedicated to transforming the field of electrophysiology by providing precise and accurate mapping and ablation solutions, enabling customized therapy options. With a patient-centric approach, Acutus Medical strives to revolutionize the treatment of complex arrhythmias and enhance the quality of life for individuals with cardiac conditions. By continually pushing boundaries and embracing a culture of excellence, Acutus Medical is at the forefront of revolutionizing electrophysiology interventions.
6 analyytikkoa arvioi tällä hetkellä Acutus Medical-osaketta: 0 suosittaa ostoa, 3 pitoa ja 3 myyntiä. Vuodelle 2026 analyytikot odottavat Acutus Medical-yhtiöltä 98,80 M USD liikevaihtoa ja −1,35 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Acutus Medical-osake noteerataan hintaan 0,00 EUR (0,00 USD).
Acutus Medical-osake (AFIB) on listattuna 1 pörssissä, muun muassa: NASDAQ (AFIB).
Acutus Medical Inc is a leading company in the field of electrophysiological imaging in medicine. Through the use of state-of-the-art technology and advanced imaging solutions, the company offers a wide range of products and services for the treatment of cardiac arrhythmias.
odotettu liikevaihto Acutus Medical on 98,80 M USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Acutus Medical on −40,19 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Acutus Medical:n hinta-voitto-suhde (P/E) on tällä hetkellä −0,00. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Acutus Medical-osakkeen arvostusta.
Acutus Medical:n hinta-myynti-suhde (P/S) on tällä hetkellä 0,00. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Acutus Medical-osakkeen arvostuskennuslukuna.
Acutus Medical:n Eulpool-laatuscore on 2/10.
Acutus Medical:n ISIN on US0051111096. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Acutus Medical:n ticker on AFIB. Tämä pörssinoteeraus käytetään Acutus Medical-osakkeiden kauppaan pörssissä.
Acutus Medical osake
Acutus Medical vertaisryhmä
Acutus Medical Ticker
Acutus Medical FIGI
Kaikki tunnusluvut ja syvällinen analyysi Acutus Medical:sta
Meidän osakeanalyysimme Acutus Medical-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Acutus Medical:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: